About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Boston | 363 Studies

Clinical Trials Colorectal CancerBoston

Colorectal Cancer Clinical Trials in Boston

Find 363 clinical trials for colorectal cancer near Boston, Massachusetts. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 101-120 of 363 trials

CompletedUsing Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal CancerThe purpose of this study is to investigate whether bevacizumab helps 5-Fluorouracil (5-FU) be delivered to the tumor more efficiently.NCT00165568·Boston, Massachusetts and 1 other CompletedA Study of ARRY-438162 (MEK162) in Patients With Advanced CancerThis is a Phase 1 study during which patients with advanced solid tumors will receive investigational study drug ARRY-438162 (MEK162). This study has 3 parts.NCT00959127·Los Angeles, California and 9 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation StudyThis is a phase 3, randomized, double-blind, placebo-controlled multi-center study evaluating the efficacy of pegfilgrastim to reduce the incidence of febrile neutropenia (FN) in…NCT00911170·Muscle Shoals, Alabama and 153 others

RecruitingA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Researchers are looking for a better way to treat people who have solid tumors with HER2-activating mutations.NCT06760819·Birmingham, Alabama and 53 others

CompletedImproving Care After ChemotherapyThe main purpose of this study is to examine changes in patient-reported symptoms during the first two cycles of neoadjuvant or adjuvant chemotherapy for non-small cell lung…NCT01944137·Boston, Massachusetts

CompletedLYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid TumorsA Phase 1/2 Open-label, Multi-center Study of the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and in Combination with Chemotherapy or Tislelizumab in…NCT04666688·Los Angeles, California and 11 others

CompletedStudy of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal CancerThe purpose of this study is to determine whether overall survival is prolonged in subjects with metastatic, epidermal growth factor receptor (EGFR)-positive colorectal cancer…NCT00063141·Tucson, Arizona and 187 others

Active not recruitingA Study of Botensilimab and Balstilimab for the Treatment of Colorectal CancerThis is an open-label, Phase 2, multicenter study to evaluate the efficacy, safety, tolerability, and pharmacokinetic profiles of botensilimab as monotherapy and in combination…NCT05608044·Scottsdale, Arizona and 64 others

Not yet recruitingMedically Tailored Meals to Reduce Ultra-processed Food Intake in Colorectal Cancer SurvivorsThis research study is a three-arm, parallel-group randomized clinical trial that examines the feasibility and initial impact of consuming medically tailored meals to reduce…NCT07701707·Boston, Massachusetts

Not yet recruitingA Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial EnrollmentMany clinical trials evaluating cancer treatments require patients to undergo testing for specific molecular markers as part of eligibility screening, typically using…NCT07814872·Boston, Massachusetts

RecruitingA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal CancerThe purpose of this study is to evaluate the safety and efficacy of pumitamig in combination with chemotherapy versus bevacizumab in combination with chemotherapy in participants…NCT07221357·Tucson, Arizona and 285 others

CompletedA Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerThis study will assess the efficacy and safety of continuous oral Xeloda administration in combination with intravenous irinotecan as a first-line treatment in patients with…NCT00048126·Hoover, Alabama and 9 others

CompletedS0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically RemovedRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00049335·Mobile, Alabama and 89 others

CompletedErbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to ChemotherapyThis is a phase II, multicenter, open-label study of cetuximab in patients with epidermal growth factor receptor (EGFR) negative, metastatic colorectal carcinoma who have…NCT00083720·Campbell, California and 26 others

Active not recruitingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersTTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase 2 dose of TTX-080 monotherapy…NCT04485013·Tucson, Arizona and 40 others

CompletedPerioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical ResectionThe purpose of this research study is to addresses the challenge of managing the unique perioperative needs of older cancer patients undergoing surgical resection.NCT02810652·Boston, Massachusetts

RecruitingPerformance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal CancerThe performance of SGM-101, an intraoperative imaging agent, will be compared to that of standard "white light" visualization during surgical resections of colorectal cancer.NCT03659448·Duarte, California and 10 others

Active not recruitingFeasibility of the LUM Imaging System for Detection of Gastrointestinal CancersThe overall goal of this feasibility study is to assess the initial safety and efficacy of LUM015 in ex vivo far-red imaging of colorectal, pancreatic, and esophageal cancers…NCT02584244·Boston, Massachusetts

CompletedExercise and Metformin in Colorectal and Breast Cancer SurvivorsMetformin is a medication that is commonly used in the treatment of diabetes.NCT01340300·New Haven, Connecticut and 1 other

RecruitingA Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal CancerCRC is the third most common type of cancer diagnosed worldwide with developed countries at highest risk.NCT06820463·Duarte, California and 81 others

PreviousPage 6 of 19Next

Other Conditions in Boston

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma